Jump to: Authorized Access | Attribution | Authorized Requests

Study Description

Generalized vitiligo is an autoimmune disease in which melanocyte loss results in patchy depigmentation of skin and hair. For this GWAS of generalized vitiligo, 579,146 SNPs were genotyped in 1514 generalized vitiligo cases of European-derived white (CEU) ancestry versus data from 2813 "public" CEU controls. 49 strongly associated SNPs from the first phase of the GWAS were then tested in two replication studies, one comparing 677 independent cases and 1106 CEU controls, and the other a family-based analysis of 204 CEU simplex generalized vitiligo trios and 310 CEU multiplex families. Overall, significant association of generalized vitiligo was detected for SNPs in several genes previously associated with other autoimmune diseases, including MHC class I (P = 9.05 x 10-23) and class II (P = 4.50 x 10-34) loci, PTPN22 (P = 1.31 x 10-7), LPP (P = 1.01 x 10-11), IL2RA (P = 2.78 x 10-9), UBASH3A (P = 1.26 x 10-9), and C1QTNF6 (P = 2.21 x 10-16). Association was also detected for SNPs in two novel immune-related loci, RERE (P = 7.07 x 10-15), GZMB (P = 3.44 x 10-8), and in a locus that may mediate melanocyte target cell specificity, TYR (P = 1.60 x 10-18) encoding tyrosinase. These findings thus demonstrate association between generalized vitiligo and multiple genes, some associated with other autoimmune diseases and others that may mediate target-cell specificity, and suggest a possible inverse relationship between susceptibility to vitiligo versus melanoma.

Authorized Access
Publicly Available Data
Study Inclusion/Exclusion Criteria

Cases:

  • Inclusion: CEU: must meet strict clinical diagnostic criteria for generalized vitiligo
  • Exclusion: CEU: must not have any form of congenital hypopigmentation, segmental vitiligo, any questionable diagnosis

Controls:

  • Inclusion: CEU
  • Exclusion: Vitiligo or any hypopigmentation disorder, any known relative with vitiligo

Trios:

  • Case plus parents (affected or not affected)

Multiplex families:

  • Case plus at least one other affected relative (not parent), plus as many connecting relatives as possible

Molecular Data
TypeSourcePlatformNumber of Oligos/SNPsSNP Batch IdComment
Whole Genome Genotyping Illumina Human660W-Quad_v1_A 592839 1048965
Selected Publications
Diseases/Traits Related to Study (MeSH terms)
Authorized Data Access Requests
Study Attribution
  • Principal Investigator
    • Richard A. Spritz, MD. University of Colorado Denver, Aurora, CO, USA.
  • Institute
    • Human Medical Genetics and Genomics Program.
  • Funding Source
    • R01AR056292. National Institutes of Health, Bethesda, MD, USA.